FAQ
Quoted figures refer to the total cell count at the time of preparation.
Cell counting begins within 48 hours of umbilical cord or placental acquisition. Final counts are performed during harvesting at Passage 3, using an automated cell counter for accuracy and consistency.
Because our therapies are prepared fresh, timing is coordinated closely with each patient’s presence at the clinic.
Viability typically ranges between 92% and 95% at administration.


